Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Junichiro, Ota"'
Autor:
Tsunehisa Sakajiri, Hisami Sameshima, Hideto Hirotsune, Naomi Ijichi, Kyoko Hazama, Yoichi Kawaike, Junichiro Ota, Chikako Imamura, Satoshi Tanaka, Shinji Ijichi, Yoshihiro Nakadoi, Kiwamu Tanaka, Arata Oiji, Kazumasa Kimura
Publikováno v:
Child's Nervous System. 33:1429-1432
Autor:
Saburo, Matsubara, Nobuo, Anzai, Junichiro, Ota, Tetsuro, Ohmori, Akira, Kodaka, Shigeki, Sato, Iwao, Sano, Kunitoshi, Hatou, Masahiko, Mikuni, Yoshio, Yamanouchi, Akira, Yoshizumi, Yoshifumi, Watanabe
Publikováno v:
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. 118(9)
In 2014, Japanese Ministry of Health, Labour and Welfare published the guideline on the policy of the psychiatric hospitals. We executed a survey to the members of "The Japanese Society of Psychiatry and Neurology" about the impression of this guidel
Autor:
Chihiro, Matsumoto, Tsuyoshi, Akiyama, Toshimasa, Maruta, Susumu, Higuchi, Hideyuki, Nakane, Junichiro, Ota, Shigenobu, Kanba
Publikováno v:
Psychiatry and clinical neurosciences. 70(10)
Autor:
Hideyuki Nakane, Tsuyoshi Akiyama, Shigenobu Kanba, Chihiro Matsumoto, Susumu Higuchi, Toshimasa Maruta, Junichiro Ota
Publikováno v:
Psychiatry and Clinical Neurosciences. 70:422-423
Publikováno v:
International Journal of Urology. 13:1019-1021
Prostate-specific antigen (PSA) decline after discontinuation of estramustine phosphate (EMP) is extremely rare. We report a case with dramatic PSA decline after withdrawal of EMP. A patient with prostate cancer had been treated with luteinizing horm
Autor:
Junichiro, Ota
Publikováno v:
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. 115(7)
In Japan, the involuntary outpatient treatment system like the Community Treatment Order is defined only in the Medical Treatment and Supervision Act 2005. However, in our outreach approach activities in the community, our treatment may seem to be in
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association. 13(7)
Prostate-specific antigen (PSA) decline after discontinuation of estramustine phosphate (EMP) is extremely rare. We report a case with dramatic PSA decline after withdrawal of EMP. A patient with prostate cancer had been treated with luteinizing horm